Ticker Details
LeMaitre Vascular, Inc. LeMaitre Vascular Inc provides medical devices and human tissue cryopreservation services for the treatment of peripheral vascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons.
IPO Date:	October 19, 2006
Sector:	Healthcare
Industry:	Health Care Equipment and Supplies
Market Cap:	$1.87B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.50 | 1.93%
Avg Daily Range (30 D):	$2.04 | 2.14%
Avg Daily Range (90 D):	$1.88 | 1.88%

Institutional Daily Volume
Avg Daily Volume:	.07M
Avg Daily Volume (30 D):	.3M
Avg Daily Volume (90 D):	.25M

Trade Size
Avg Trade Size (Sh.):	61
Avg Trade Size (Sh.) (30 D):	40
Avg Trade Size (Sh.) (90 D):	39

Institutional Trades
Total Institutional Trades:	1,896
Avg Institutional Trade:	$1.84M
Avg Institutional Trade (30 D):	$2.83M
Avg Institutional Trade (90 D):	$3.41M
Avg Institutional Trade Volume:	.03M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.95M
Avg Closing Trade (30 D):	$4.3M
Avg Closing Trade (90 D):	$4.69M
Avg Closing Volume:	28.97K

News

May 5, 2026 @ 8:05 PM LeMaitre Q1 2026 Financial Results Source: Na

Mar 28, 2026 @ 12:06 AM LeMaitre Vascular Up 30% as Insider Sells $285K in... Source: Jonathan Ponciano

Feb 27, 2026 @ 7:50 PM LeMaitre to Participate at Upcoming Investor Confe... Source: Na

Oct 9, 2025 @ 9:53 PM LeMaitre Will Announce Third Quarter 2025 Earnings... Source: Lemaitre Vascular, Inc.

Aug 6, 2025 @ 5:09 AM LeMaitre (LMAT) Q2 Revenue Jumps 15% Source: Jesterai

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$2.89	$.75	$.69
Diluted EPS	$2.85	$.74	$.68
Revenue	$262.43M	$70.38M	$66.55M
Gross Profit	$191.31M	$50.76M	$48.4M
Net Income / Loss	$65.67M	$17.05M	$15.68M
Operating Income / Loss	$77.32M	$20.4M	$17.78M
Cost of Revenue	$71.13M	$19.62M	$18.16M
Net Cash Flow	$-.3M	$-.17M	$-1.25M
PE Ratio